REGENERON PHARMACEUTICALS INC revenue for the last year amounted to 222.80 B MXN, the most of which — 222.80 B MXN — came from its highest performing source at the moment, Medicines, the year earlier bringing 237.43 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought REGENERON PHARMACEUTICALS INC 114.71 B MXN, and the year before that — 133.03 B MXN.